Cargando…
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update
BACKGROUND: Since 2020, annual reports on the clinical development of new drug-based therapies for the neurodegenerative condition of Parkinson’s disease (PD) have been generated. These reviews have followed the progress of both “symptomatic treatments” (ST – improves/reduces symptoms of the conditi...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IOS Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357160/ https://www.ncbi.nlm.nih.gov/pubmed/37302040 http://dx.doi.org/10.3233/JPD-239901 |